Austria vs Brunei Darussalam: The number of people with susceptibility test result for rifampicin
Austria
165
in 2021
Brunei Darussalam
162
in 2021
Austria rank
98th
Brunei Darussalam rank
99th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Brunei Darussalam
How they compare
Austria currently reports 165 against 162 in Brunei Darussalam, a difference of 3.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 98th and Brunei Darussalam ranks 99th of 155 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Brunei Darussalam in 1.
Head to head by decade
| Decade | Austria | Brunei Darussalam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.67 | 187 | 33.67 | Austria |
| 2020s | 169 | 195.5 | 26.5 | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Brunei Darussalam?
- Austria, at 165 against 162 in Brunei Darussalam as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Brunei Darussalam?
- 3, with Austria ahead.
- How many years of comparable data are there for Austria and Brunei Darussalam?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Brunei Darussalam rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th and Brunei Darussalam ranks 99th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.